Last reviewed · How we verify
NCT04825639
Identifying Risk Factors for Developing AKI in Sepsis
trial testing No intervention in Sepsis in 300 participants. Completed in 31 March 2022.
30 March 2022
Quick facts
| Lead sponsor | Cardiff and Vale University Health Board |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 15 March 2021 |
| Primary completion | 30 March 2022 |
| Estimated completion | 31 March 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- No intervention
Conditions studied
- Sepsis — all drugs for Sepsis →
- Acute Kidney Injury — all drugs for Acute Kidney Injury →
- Diabetic Ketoacidosis — all drugs for Diabetic Ketoacidosis →
Sponsor
Cardiff and Vale University Health Board
Who can join
Adults 0 Days to 18, any sex, with Sepsis or Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A study to evaluate the prevalence of Acute Kidney Injury (AKI) in patients with Diabetic Ketoacidosis (DKA) and sepsis using data collected prospectively to a patient registry. The primary objective is to compare the prevalence of AKI in sepsis and DKA in different age groups in children and investigate the difference in the prevalence of hyperchloremia in the two groups.Secondary objectives are Compare the prevalence of AKI in sepsis and DKA in different age groups in children and investigate the difference in the prevalence of hyperchloremia in the two groups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04825639
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention
Trials testing the same drug.
- NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
- NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
- NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
Other recruiting trials for Sepsis
Currently open trials in the same condition.
- NCT07507877 — Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness · recruiting
- NCT07154615 — Assessing Immune Dysfunction in Sepsis · recruiting
- NCT07419802 — OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study · recruiting
- NCT07351344 — African Survey on Sepsis Knowledge (ASK) · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
Other Cardiff and Vale University Health Board trials
Trials by the same sponsor.
- NCT07110129 — Using sEMG of the Diaphragm to Assess Readiness for Extubation · recruiting
- NCT06967168 — HeEL Pain Pathways Feasibility Study · NA · recruiting
- NCT06363175 — PREMs In Vascular SurgERy Enhancement Study · not yet recruiting
- NCT04287959 — SWISH Trial (Strategies for Weaning Infants on Supportive High Flow) · NA · completed
- NCT03215849 — Pacing in Heart Failure With Preserved LVEF · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04825639 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardiff and Vale University Health Board
- Last refreshed: 22 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04825639.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing